Blood test could spot deadly lung complication before It's too late
NCT ID NCT07498244
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks for early signs of pulmonary hypertension (high blood pressure in the lungs) in people with chronic lung diseases like COPD or pulmonary fibrosis. Researchers will analyze collagen fragments in blood and lung tissue to create a 'fingerprint' that could lead to simpler, earlier diagnosis. The goal is to help doctors classify patients better and personalize treatment. About 80 participants are being recruited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Graz
RECRUITINGGraz, Styria, 8010, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Could a common heart drug cut COPD hospitalizations?
- Can AI catch lung scarring that doctors might miss?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?